An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors

Di Wu, Yuqian Yan, Ting Wei, Zhenqing Ye, Yutian Xiao, Yunqian Pan, Jacob J. Orme, Dejie Wang, Liguo Wang, Shancheng Ren, Haojie Huang

Producción científica: Articlerevisión exhaustiva

18 Citas (Scopus)

Resumen

Acquisition of resistance to phosphatidylinositol 3-kinase (PI3K)/AKT-targeted monotherapy implies the existence of common resistance mechanisms independent of cancer type. Here, we demonstrate that PI3K/AKT inhibitors cause glycolytic crisis, acetyl-coenzyme A (CoA) shortage, and a global decrease in histone acetylation. In addition, PI3K/AKT inhibitors induce drug resistance by selectively augmenting histone H3 lysine 27 acetylation (H3K27ac) and binding of CBP/p300 and BRD4 proteins at a subset of growth factor and receptor (GF/R) gene loci. BRD4 occupation at these loci and drug-resistant cell growth are vulnerable to both bromodomain and histone deacetylase (HDAC) inhibitors. Little or no occupation of HDAC proteins at the GF/R gene loci underscores the paradox that cells respond equivalently to the two classes of inhibitors with opposite modes of action. Targeting this unique acetyl-histone-related vulnerability offers two clinically viable strategies to overcome PI3K/AKT inhibitor resistance in different cancers. Acquisition of resistance to PI3K/AKT-targeted monotherapy regardless of cancer type implies the existence of common mechanisms. Wu et al. identify an intrinsic mechanism that not only drives PI3K/AKT inhibitor resistance but also can be vulnerably targeted paradoxically by both BET and HDAC inhibitors.

Idioma originalEnglish (US)
Número de artículo108744
PublicaciónCell Reports
Volumen34
N.º7
DOI
EstadoPublished - feb 16 2021
Publicado de forma externa

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Huella

Profundice en los temas de investigación de 'An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors'. En conjunto forman una huella única.

Citar esto